0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Ophthalmology

Not currently available

Retinal Dystrophies - Functional Genomics to Gene Therapy (Hardcover, New) Loot Price: R3,307
Discovery Miles 33 070
Retinal Dystrophies - Functional Genomics to Gene Therapy (Hardcover, New): Novartis

Retinal Dystrophies - Functional Genomics to Gene Therapy (Hardcover, New)

Novartis

Series: Novartis Foundation Symposia

 (sign in to rate)
Loot Price R3,307 Discovery Miles 33 070 | Repayment Terms: R310 pm x 12*

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

Retinal dystrophies are the major causes of incurable blindness in the Western world. Our insight into their aetiology has improved remarkably over the past decade and a number of key genes have been identified. Together with a more detailed understanding of disease processes, this knowledge is stimulating new approaches to therapeutic strategies involving gene therapy, growth factors and retinal cell transplantation.

Molecular genetic studies have provided detailed information on the pathogenesis of retinal dystrophies. An important proof of principle that gene therapy holds great promise for the treatment of these conditions was demonstrated in the "rds" mouse: introduction of a functional copy of the "peripherin" gene subretinally resulted in complete rescue of rod outer segment structure. Novel approaches are being developed based on the manipulation of biochemical pathways that previously were not considered relevant to these diseases. For example, renewed interest in retinal dystrophy pathogenesis led to the successful use of high dose vitamin A treatment in Sorsby fundus dystrophy.

This important new book covers all aspects of retinal dystrophies from the molecular and developmental biology of these disorders to possible therapeutic approaches, with special reference to gene therapy. Specific chapters deal with the molecular genetics of gene therapies, clinical genetic studies, molecular and cellular mechanisms of the development of the disease, functional genomics of retinal diseases, animal models of retinal dystrophies, and finally with studies on gene therapeutic approaches to correcting the disorder. With contributions by many of the leading researchers worldwide, this book is likely to be an important milestone in this rapidly developing field.

General

Imprint: John Wiley & Sons
Country of origin: United States
Series: Novartis Foundation Symposia
Release date: December 2003
First published: 2004
Authors: Novartis
Dimensions: 237 x 165 x 16mm (L x W x T)
Format: Hardcover
Pages: 226
Edition: New
ISBN-13: 978-0-470-85357-3
Categories: Books > Medicine > Clinical & internal medicine > Ophthalmology
Promotions
LSN: 0-470-85357-3
Barcode: 9780470853573

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners